Customer OverviewA public health research organization expanding smoking cessation studies beyond geographic limits
The ChallengeGeographic constraints, compliance requirements, and device complexity limiting decentralized trial operations
Geographic Limitation
In-person onboarding and breath analysis restricted participant enrollment to North Carolina facilities. The requirement for physical presence fundamentally capped the study's reach and prevented the organization from recruiting participants outside its immediate region.
Operational Disruption
COVID-19 accelerated the need for remote participation while maintaining study continuity. The pandemic made facility-based research operations untenable and created urgent demand for a digital infrastructure capable of supporting decentralized clinical workflows without compromising data integrity.
Secure Data Requirements
Study protocols required compliant, privacy-protected collection of sensitive participant data. Handling health information across remote environments demanded a rigorous approach to data security, access control, and regulatory compliance throughout every stage of participant engagement.
Scalability Expectations
Leadership sought an infrastructure capable of supporting national and international study expansion. The platform needed to be architected for growth from the outset, enabling additional protocols and participant populations to be incorporated without requiring fundamental re-engineering.
Device Integration Complexity
Multiple remote medical devices required structured interoperability within a unified system. Consolidating data streams from diverse device types into a single, coherent platform presented significant technical challenges that had to be resolved without disrupting study operations.
Client RequirementsNeed for a Secure, Scalable Remote Research Platform Supporting Decentralized Clinical Trials
Remote Participant Enrollment
Centralized Device Data Integration
Compliant Telehealth Communication
Role-Based and SSO Access Controls
Multi-Study Scalable Architecture
The SolutionA secure, cloud-based remote research platform enabling decentralized trial operations at scale
Remote Participant Onboarding Framework
Designed secure digital enrollment workflows, eliminating reliance on in-person visits and enabling participants across the United States and internationally to complete the full onboarding process remotely within a compliant, privacy-protected environment.
Device Integration Architecture
Integrated remote medical devices into a centralized IoT-enabled data platform for consolidated participant data access, ensuring that data from diverse device types was captured accurately and consistently within a unified system regardless of participant location.
Telemedicine Application Deployment
Built a dedicated in-app communication environment to support structured researcher–participant engagement, enabling compliant, documented interactions between study teams and remote participants throughout every phase of the clinical trial.
SSO and Role-Based Access Controls
Integrated with the client's existing Single Sign-On infrastructure to ensure compliant, segmented data access, with role-based controls ensuring each user could only access the participant data and study functions aligned to their research responsibilities.
Scalable Cloud Infrastructure
Architected a flexible backend capable of supporting multi-study expansion across geographic regions, designed to accommodate additional protocols and participant populations without requiring foundational re-engineering as the research program grows.
The ImpactMeasurable gains in participant reach, study continuity, and AI-ready research data infrastructure
Expanded Participant Reach
Enabled remote enrollment across the United States and international regions, overcoming the geographic barriers that had previously confined participation to North Carolina facilities and significantly expanding the study's accessible population.
Maintained Study Continuity
Preserved operational stability during pandemic-related disruptions through decentralized execution, allowing the research organization to continue conducting studies without interruption despite the closure of in-person research facilities.
Improved Data Reliability
Centralized device integration and structured telehealth workflows reduced manual data handling risk, improving the accuracy and consistency of participant data collected across remote environments throughout the study lifecycle.
Established AI-Ready Research Data Pipelines
Standardized real-time participant data streams capable of supporting future predictive cessation modeling and behavioral analytics, creating the governed dataset foundation needed to apply machine learning to smoking cessation research outcomes.
Positioned for Scalable Trial Expansion
Delivered a production-grade infrastructure that supported additional protocols without replatforming, giving the organization a scalable digital foundation to expand its research program across new studies, participant populations, and geographic regions.
The structured remote infrastructure significantly expanded our ability to conduct smoking cessation research beyond geographic constraints. The disciplined execution ensured data integrity while enabling scalable study growth.
Download the Case Study
Bridgera will use any of the data provided in accordance with the Privacy Policy.